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Abstract. 
 
Thy-1, a glycosylphosphatidylinositol-linked 
integral membrane protein of the immunoglobulin su-
perfamily, is a component of both large dense-core and 
small clear vesicles in PC12 cells. A majority of this 
protein, formerly recognized only on the plasma mem-
brane of neurons, is localized to regulated secretory 
vesicles. Thy-1 is also present in synaptic vesicles in rat 
central nervous system. Experiments on permeabilized 
PC12 cells demonstrate that antibodies against Thy-1 
inhibit the regulated release of neurotransmitter; this 
inhibition appears to be independent of any effect on 
 
the Ca
 
2
 
1
 
 channel. These findings suggest Thy-1 is an in-
tegral component of many types of regulated secretory 
vesicles, and plays an important role in the regulated 
vesicular release of neurotransmitter at the synapse.
 
O
 
ur 
 
understanding of the molecular mechanisms in-
volved in secretory vesicle dynamics has advanced
substantially in the past 10 yr with the identifica-
tion of many of the molecular components of secretory
vesicles. Results from reconstitution of Golgi transport
(Rothman, 1987), yeast secretion mutants (Kaiser and
Schekman, 1990), and biochemical characterization of syn-
aptic vesicles (Südhof et al., 1993; Bajjalieh and Scheller,
1995) all point to the existence of common molecular com-
ponents that carry out membrane fusion. For example, a
generalized version of the SNARE
 
1
 
 hypothesis (Söllner et al.,
1993) suggests that a precisely choreographed interplay
between synaptic vesicle proteins, plasma membrane pro-
teins, and cytoplasmic proteins results in Ca
 
2
 
1
 
-stimulated
membrane fusion. However, the specific details of many of
the processes and molecular components involved in vesi-
cle dynamics remain poorly defined.
Neurons and endocrine cells are highly specialized to
carry out regulated secretion from membrane-bounded
storage vesicles when an appropriate stimulus is applied.
At least two distinct types of regulated secretory vesicles
coexist within neurons and endocrine cells; these or-
ganelles are typically referred to as small synaptic, or syn-
aptic-like vesicles (SSVs) and large, dense-core vesicles
(LDCVs). SSVs and LDCVs differ in a variety of physical
and functional properties, including size, density, contents,
membrane components, location within cells, biogenesis,
and kinetics of release. Despite the differences, these two
types of vesicles share many common properties, including
transport to the vicinity of specialized release sites, close
apposition to specialized sites on the plasma membrane,
and the ability to fuse with the plasma membrane in a
highly regulated manner, typically in response to an eleva-
tion in intracellular free Ca
 
2
 
1
 
 concentration.
A first step in the biochemical approach to understand-
ing regulated secretion involves the identification of the
components of the secretory vesicles. A considerable num-
ber of such proteins have now been identified. These in-
clude the synaptotagmins (Matthew et al., 1981), SV2 (Buck-
ley and Kelly, 1985), synaptophysin/P38 (Jahn et al., 1985;
Wiedenmann and Franke, 1985), the synapsins (De Cam-
illi and Greengard, 1986), synaptobrevin, (Trimble et al.,
1988; Baumert et al., 1989), rab 3A (Fisher von Mollard et al.,
1990), the cysteine string protein (Zinsmaier et al., 1990;
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large dense-core vesicle; NE, norepinephrine; NMS, normal mouse serum;
NSF, N-ethylmaleimide sensitive factor; SAC, staphylococcus aureus;
SNAP, soluble NSF attachment protein; SNARE, SNAP receptor; SSV,
small synaptic vesicle.
  
The Journal of Cell Biology, Volume 140, 1998 686
 
Gunderson and Umbach, 1992), and synaptogyrin/P29
(Baumert et al., 1990; Stenius et al., 1995). These proteins
are present in all SSVs irrespective of the specific neu-
rotransmitter content (De Camilli and Jahn, 1990). Some,
such as synaptotagmin and SV2, are found in both SSVs
and LDCVs (Lowe et al., 1988), whereas others, such as
synaptophysin and the synapsins, are associated predomi-
nantly or exclusively with SSVs (Navone et al., 1984; Na-
vone et al., 1986). Although many of the synaptic vesicle
proteins mentioned above were initially identified only as
uncharacterized proteins specifically associated with vesi-
cles, considerable information has now been obtained
about their interactions and possible functions (for review
see Südhof, 1995).
PC12 cells (Greene and Tischler, 1976) are neuroendo-
crine cells that contain both LDCVs that store and release
catecholamines (Greene and Rein, 1977; Wagner, 1985)
and small clear vesicles that contain ACh (Bauerfeind et al.,
1993). The small clear vesicles of these and other neuroen-
docrine cells are biochemically very similar to the neu-
ronal SSVs (Navone et al., 1986; Lowe et al., 1988; Oben-
dorf et al., 1988; Johnston et al., 1989; Navone et al., 1989;
Grote and Kelly, 1996). Based on the expectation that pro-
teins, that play a fundamental role in regulated secretion
should be found as components of both LDCVs and SSVs,
we have searched for components found on both popula-
tions of regulated secretory vesicles in PC12 cells. We re-
port here our unexpected finding that one such protein
is Thy-1, a glycosyl-phosphatidylinositol (GPI)–linked in-
tegral membrane protein of the immunoglobulin super-
family.
Thy-1 was initially described on the cell surface of T lym-
phocytes in mouse (Reif and Allen, 1964; Acton et al.,
1974), but in fact this protein is more characteristic of neu-
rons than of lymphocytes, as it is expressed in nervous sys-
tem tissue in virtually all mammalian species (Morris et al.,
1983; Morris, 1985). Thy-1 shares structural homologies
with immunoglobulins (Campbell et al., 1981; Cohen et al.,
1981; Williams and Gagnon, 1982); unlike many other
members of this superfamily, the mature form of Thy-1
does not cross the lipid bilayer, but is anchored to the lu-
menal (extracellular) leaflet by covalent linkage to phos-
phatidylinositol (Low and Kincade, 1985; Tse et al., 1985).
It is known to be expressed by neurons and neuronal cells
in culture (Mahanthappa and Patterson, 1992; Wilkerson
and Touster, 1993), where it has been used as a marker for
plasma membrane (Green and Kelly, 1992). However, a
clue to an intracellular localization of Thy-1 comes from
the observation that Thy-1 accumulates proximal to a
nerve compression, suggesting that there is an intracellular
form that is transported down axons by intraaxonal trans-
port (Morris et al., 1983).
Despite its lack of a transmembrane domain, Thy-1 has
been implicated in signal transduction, through increasing
in intracellular Ca
 
2
 
1
 
 (Kroczek et al., 1986; Barboni et al.,
1991) and stimulating tyrosine phosphorylation (Hsi et al.,
1989; Garnett et al., 1993). Either cross-linking or removal
of cell surface Thy-1 triggers differentiation and neurite
outgrowth in both primary neurons and PC12 cells (Leifer
et al., 1984; Mahanthappa and Patterson, 1992). 
There have been a few provocative indications that Thy-1
might be involved directly with synaptic transmission. An-
tibodies against Thy-1, when injected into the hypothala-
mus, have been reported to have an effect on drinking be-
havior (Williams et al., 1980). Most intriguing, knockout
mice lacking Thy-1 show a specific deficit in long-term po-
tentiation (LTP) in the dentate gyrus of the hippocampus
(Nosten-Bertrand et al., 1996); this deficit has been con-
firmed by recordings from awake knockout animals (Err-
ington et al., 1997).
We have found that Thy-1 is a component of multiple
types of regulated secretory vesicles, both in cultured cells
and in vivo. We have obtained evidence for the functional
involvement of this protein in the regulated, Ca
 
2
 
1
 
-depen-
dent release of norepinephrine (NE), using two indepen-
dent in vitro release systems derived from PC12 cells. The
presence of Thy-1 in multiple populations of secretory ves-
icles in most neuronal cells argues that this protein plays a
fundamental role in regulated secretion at the synapse.
 
Materials and Methods
 
Generation of Monoclonal Antibodies
 
Monoclonal antibodies were prepared using BALB/c mice, according to
standard procedures (Goding, 1986), by fusing spleen cells to SP2/0 my-
eloma cells. Antigen was prepared by homogenizing PC12 cells in Hepes-
buffered saline (HBS, 150 mM NaCl, 10 mM Hepes, pH 7.4) in the presence
of 1 mM EGTA, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin, 1 
 
m
 
g/ml aprotinin,
1 
 
m
 
g/ml antipain, and 0.2 mM diisopropylfluorophosphate. Secretory vesi-
cles were purified by layering homogenates onto 1–27% ficoll gradients in
0.32 M sucrose, 10 mM Hepes, pH 7.4, and centrifuging at 100,000 
 
g
 
 for 16 h
at 4
 
8
 
C (Schweitzer and Kelly, 1985). Vesicle fractions were collected from
the gradients, pooled, diluted with 5 vol H
 
2
 
O at 0
 
8
 
, and freeze thawed five
times to release soluble proteins. Membranes were then pelleted by cen-
trifugation at 120,000 
 
g
 
 for 1 h, and emulsified in Freund’s complete adju-
vant to immunize mice.
After selection and cloning of hybridoma cells, antibody-containing
culture media were screened for their ability to bind to purified PC12
secretory vesicles and for their vesicular pattern of staining by immunoflu-
orescence microscopy.
 
Other Antibodies and Reagents
 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO),
unless otherwise indicated. Reagents for SDS-PAGE were obtained from
Bio-Rad Laboratories (Hercules, CA) and Fisher Scientific Co. (Fairlawn,
NJ). Cell culture medium and reagents were obtained from GIBCO BRL
(Gaithersburg, MD). Nitrocellulose membrane filters were from Micron
Separation Inc. (Westboro, MA). 
 
Staphylococcus aureus
 
 pansorbin was
purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA). Anti-
SV2 antibody was monoclonal 10H3 (Buckley and Kelly, 1985), antisyn-
aptogyrin antibody (clone 80.1) was a gift from R. Jahn (Yale University
School of Medicine, New Haven, CT), antisecretogranin I antibody (clone
219.6) was a gift from P. Rosa (University of Milan, Milan, Italy), and an-
tisodium pump antibody (McK1) was a gift from K. Sweadner (Massa-
chusetts General Hospital, Boston, MA). Anti-SNAP-25 antibody was ob-
tained from Sternberger Monoclonals Inc. (Baltimore, MD). Monoclonal
antibody (OX7) against Thy-1 was obtained from PharMingen (San
Diego, CA). Antisynaptophysin antibody, peroxidase-conjugated goat
anti–mouse antibody and alkaline phosphatase-conjugated goat anti–
mouse antibody were obtained from Boehringer Mannheim Biochemicals
(Indianapolis, IN). Biotinylated sheep anti–mouse antibody and Texas
red–streptavidin were from Amersham Corp. (Arlington Heights, IL).
ABC kit was obtained from Vector Labs Inc. (Burlingame, CA).
 
Cell Culture
 
Subcloned PC12 cells (Schweitzer and Paddock, 1990), were grown in
DME with 25 mM Hepes plus 5% supplemented calf serum (HyClone,
Logan, UT), 5% horse serum (HyClone), and penicillin plus streptomycin
at 9.5% CO
 
2
 
. Cells to be used for microscopy were pretreated for 3 d with
10 ng/ml NGF to induce cell differentiation. They were then trypsinized 
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and replated onto poly-D-lysine–coated coverslips and grown in the con-
tinued presence of NGF for an additional 3 d before fixation and processing.
CHO fibroblast cells were maintained in Ham’s F12 medium containing
5% calf serum (HyClone), penicillin, streptomycin, and fungizone. Mon-
key kidney (COS) cells were maintained in DME containing 10% calf se-
rum, penicillin, and streptomycin.
 
Density Gradient Fractionation
 
PC12 cells were labeled overnight with 0.5 
 
m
 
Ci/ml of [
 
3
 
H]NE. Cells were
harvested with HBS plus 5 mM MgEGTA, and homogenized with a stain-
less steel ball bearing homogenizer (EMBL [European Molecular Biology
Laboratory], Heidelberg, Germany) at 0
 
8
 
C. The entire cell homogenate
was loaded on the top of a linear sucrose density gradient (0.6 –1.6 M su-
crose in 10 mM Hepes, pH 7.4, 1 mM MgEGTA). The gradient was centri-
fuged for 18 h at 97,000 
 
g
 
 in a Ti rotor (SW41; Beckman Instruments). The
contents of the centrifuge tube were recovered by dropwise collection
from the bottom of the tube. After collecting the gradients, the material
pelleted at the bottom of the tube was resuspended and collected as frac-
tion number one. The fractionated samples were subsequently used for
scintillation counting and dot blot immunoassay.
 
Dot Blot Immunoassay and Western Blot
 
For dot blot immunoassays, nitrocellulose membranes were soaked in
TBS (150 mM NaCl, 10 mM Tris, pH 7.4), drained on filter paper, and
then mounted on a 96-well manifold (Bio-Rad Laboratories). A 5-
 
m
 
l sam-
ple from each fraction of the sucrose density gradient was diluted with 195 
 
m
 
l
transfer buffer (192 mM glycine, 20 mM Tris base, 20% methanol; Towbin
et al., 1979). Each sample was applied to a separate well of the manifold
under low vacuum with a slow filtration rate. The manifold was then disas-
sembled and the filter left to air dry.
For Western blots, proteins were dissolved in 2
 
3
 
 SDS sample buffer
and boiled, with the exception of samples used to quantitate the plasma
membrane Na pump, which were allowed to incubate at room tempera-
ture for 15 min before loading onto gels. Samples were subjected to SDS-
PAGE on 8, 10, or 12% polyacrylamide gels (Laemmli, 1970), in the pres-
ence or absence of 
 
b
 
-mercaptoethanol, and electrotransferred onto 0.45 
 
m
 
m
nitrocellulose filters for 1 h at 100 mA in 25 mM Tris-base, 192 mM gly-
cine, and 20% methanol (Towbin et al., 1979) by a semi-dry transfer appa-
ratus (TE70; Hoefer Scientific Instruments, San Franscisco, CA). Molecu-
lar weights were estimated by comparison with molecular weight standards
purchased from Sigma Chemical Co. or Bio-Rad Laboratories, and
stained with Ponceau S dye.
The filters were blocked by soaking in 5% (wt/vol) Carnation nonfat
dry milk in TBST (0.1% Tween-20 in TBS) for 1 h. All the incubation and
washing procedures were carried out at room temperature with gentle ag-
itation. After blocking, filters were incubated with tissue culture superna-
tant or 1:5,000 dilution of ascites fluid diluted in 1% (wt/vol) nonfat dry
milk in TBST for 1 h followed by three washes in TBST.
Bound antibodies were visualized by either enhanced chemilumines-
cence (ECL) or alkaline phosphatase methods. For ECL, filters were in-
cubated with 1:1,000 dilution of horseradish peroxidase–conjugated goat
anti–mouse in TBST containing 1% milk for 1 h, and then washed again as
above. After draining off excess buffer, membranes were incubated in the
detecting reagents (5 mM luminol, 1 mM 4-indophenol and 0.2 mM H
 
2
 
O
 
2
 
in 150 mM NaCl, 50 mM Tris, pH 9.0) (Thorpe et al., 1985; ECL Western
blotting detection system, Amersham, Oakville, Ontario; Dupont REN-
AISSANCE Western blot Chemiluminescence system, Dupont, Wilming-
ton, DE) for 1 min. Excess detecting reagents was drained off from the
membrane, and it was then wrapped in Saran wrap and exposed to Kodak
X-OMAT AR film (Eastman Kodak Co., Rochester, NY) for 15–60 s. The
films were then scanned and analyzed using a scanning densitometer
(model GS-700; Bio-Rad Laboratories) with Molecular Analyst software.
For alkaline phosphatase detection, alkaline phosphatase-coupled sec-
ondary antibodies were used, and quantitated by incubation with a color
substrate (0.01% nitro-blue tetrazolium, 0.005% 5-bromo-4-chloro-3-
indolylphosphate and 4 mM MgCl
 
2
 
 in 45 mM bicarbonate buffer, pH 9.6).
 
Immunofluorescence Microscopy
 
For standard antibody labeling, PC12 cells treated with NGF were grown
on poly-D-lysine–coated eight-well slides. On the third day, cells were
rinsed with HBS plus 10 mM CaCl
 
2
 
 and 10 mM MgCl
 
2
 
 (CM-HBS) and
fixed in modified Bouin’s fixative (Schweitzer and Paddock, 1990) for 10
min. Cells were then washed with HBS, incubated with 50 mM NH
 
4
 
Cl in
HBS for 5 min, permeabilized with 0.1% Triton X-100 in HBS for 2 min,
and blocked with 1% nonfat milk (in HBS plus 10 mM MgEGTA) for 10
min. Cells were incubated with primary antibodies for 1 h at 37
 
8
 
C. After
washing, cells were further incubated with biotinylated goat anti–mouse
antibodies and then Texas red streptavidin. After washing with HBS and
distilled water, slides were mounted in 2% triethylene diamine in glycerol,
pH 8.6 (Bock et al., 1985). Confocal images were acquired with a Zeiss 410
laser scanning microscope.
To stain nonpermeabilized cells, PC12 cells on coverslips were chilled
by placing on ice, and then incubated for 1 h in the presence of and appro-
priate dilution of primary antibody. After this incubation, the cells were
washed three times with ice-cold buffer, and fixed and processed as above.
Control experiments with a mouse antitubulin antibody demonstrated
that this procedure resulted in no labeling of intracellular structures.
 
Cloning of the 7C8 Antigen
 
Library Screening. 
 
A rat PC12 cell line cDNA library was constructed in
the plasmid expression vector CDM8 (Seed and Aruffo, 1987) and trans-
fected into CHO cells as previously described (Liu et al., 1992). The stable
transformants were plated at low density (
 
z
 
1,500 cells/15-cm plate) and
overlaid the following day with a 17-
 
m
 
m pore polyester replica filter
(Esko, 1986). After 5 d, filters containing cell colonies from 20 15-cm
plates were removed, fixed in 4% formaldehyde from paraformaldehyde,
washed in Ca
 
2
 
1
 
- and Mg
 
2
 
1
 
-free phosphate-buffered saline, blocked in 3%
normal goat serum, 0.01% Triton X-100, and incubated overnight at 4
 
8
 
C in
7C8 ascites diluted 1:10,000, 1% goat serum, and 0.01% Triton X-100. The
filters were washed six times in 1% goat serum and 0.01% Triton X-100, and
incubated in biotin-conjugated goat anti–mouse IgM antiserum, followed
by an avidin–biotin complex conjugated to alkaline phosphatase (Vector
Labs, Inc.). For secondary screening, a lower density of cells (
 
z
 
100 cells/
10-cm plate) was used. Double-stranded DNA sequencing was performed
using fluorescent nucleotides in an automated sequencing apparatus.
 
Plasmid Rescue. 
 
Genomic DNA was extracted by homogenization with
5 M guanidinium thiocyanate and precipitation with isopropanol. The in-
tegrated plasmid DNA was excised, religated, and transformed into 
 
Es-
cherichia coli
 
 as described previously (Feany et al., 1992). From each of
the three sets of colonies transformed with DNA from independent CHO
cell lines, plasmid DNA was prepared from 30 to 60 colonies. DNA from
one of the three sets was pooled, and then radiolabeled using a random-
primer labeling kit (Stratagene, La Jolla, CA). DNA preps derived from
the other two sets of colonies were subjected to a PstI/HindIII digest to
excise the cDNA insert from the CDM8 vector, electrophoresed through
agarose, and blotted to nitrocellulose filters that were probed with the ra-
diolabeled, independently isolated DNA.
 
Cell Transfections. 
 
For transient transfections, COS cells were elec-
troporated with 15 to 30 
 
m
 
g DNA using a Gene Pulser apparatus (Bio-
Rad Laboratories) as previously described (Peter et al., 1994).
 
Cell Surface Biotinylation
 
Biotinylation was performed by a modification of the procedure described
by Schmidt et al. (1997). All steps were performed at 4
 
8
 
C. Subconfluent
15-cm dishes of PC12 cells were rinsed three times with 10 ml CM-PBS
(136 mM NaCl, 2.5 mM KCl, 1.5 mM KH
 
2
 
PO
 
4
 
, 6.5 mM Na
 
2
 
HPO
 
4
 
, 0.5 mM
CaCl
 
2
 
, and 2 mM MgCl
 
2
 
). After removing the rinse, the biotinylation was
started by the addition to each dish of 4 ml CM-PBS containing 4 mg
sulfo-NHS-LC-biotin (Pierce, Rockford, IL), followed by incubation at
0
 
8
 
C for 30 min with slow shaking. Biotinylation was terminated by remov-
ing the medium and rinsing dishes three times with CM-PBS buffer and
three times with HBS.
 
Immunoprecipitations
 
Immunoisolation of Vesicles. 
 
For immunoisolation of SV2-containing vesi-
cles, 
 
S. aureus
 
 cells (SAC; Calbiochem-Novabiochem. Corp.), pretreated
with rabbit anti–mouse antibody, were incubated with anti-SV2 mono-
clonal antibodies, clone 10H3 (Buckley and Kelly, 1985) or normal mouse
serum (NMS) diluted in HBS for 1 h on ice. SV2-coated SAC, or NMS-
treated SAC, was washed in HBS and incubated with postnuclear super-
natant of PC12 cells for 1 h at 4
 
8
 
C under slow rotation. Samples were spun
for 5 min at 2,000 
 
g
 
 and washed three times in HBS. The pellet and super-
natant were then subjected to SDS-PAGE and immunoblotting.
 
Thy-1 Immunoprecipitation. 
 
OX7-coated SAC was prepared by pre-
treating SAC with rabbit anti–mouse antibodies and then with OX-7 anti-
body. A postnuclear supernatant of PC12 cells was solubilized with Det- 
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HBS (1% Nonidet P40, 0.3% SDS, 0.4% deoxycholate, 66 mM EDTA, 10
mM Hepes, pH 7.4), and then incubated with OX7-coated SAC for 1 h at
4
 
8
 
C with slow rotation. Samples were centrifuged for 5 min at 2,000 
 
g
 
, and
washed once with Det-HBS and twice with HBS. The pellets and superna-
tants were then boiled in SDS sample buffer and subjected to SDS-PAGE
and immunoblotting.
 
Subcellular Fractionation and Purification of Synaptic 
Vesicles from Rat Brains
 
Synaptic vesicles were purified under isoosmotic conditions as described
previously (Floor et al., 1995). Briefly, rat brains were homogenized in
0.32 M sucrose, 5 mM Na
 
2
 
HPO
 
4
 
 at pH 6.6, 1 mM EGTA, and 0.02%
NaN
 
3
 
. An equal volume CK buffer (0.16 M KCl, 5 mM NaHPO
 
4
 
 at pH 6.6,
1 mM EGTA, 0.02% NaN
 
3
 
, and 1 mM dithiothreitol was added, the sus-
pension was centrifuged at 7,500 
 
g
 
 for 25 min, and the resulting superna-
tant was centrifuged at 60,000 
 
g
 
 for 3 h. The resulting pellet was resus-
pended in CK buffer and loaded on 10–30% (wt/vol) nycodenz gradients
and centrifuged at 100,000 
 
g
 
 for 2 h in a vertical rotor. Fractions contain-
ing synaptic vesicles were pooled and further chromatographed on a
Sephacryl S-1000 column in CK buffer. Both LDCVs and SSVs are en-
riched 
 
z
 
30-fold in peak fractions after Sephacryl S-1000 chromatography.
 
Immunohistochemistry
 
Rats were anesthetized and perfused with 4% paraformaldehyde/HBS.
Tissue blocks were further fixed by immersion in the same fixative for 3 h
at 4
 
8
 
C and then soaked in 20% sucrose/HBS overnight at 4
 
8
 
C for cryostat
sectioning. Sections (10 
 
m
 
m in thickness) were rinsed with HBS buffer,
permeabilized with 0.3% Triton X-100/HBS for 15 min, and then treated
with 0.3% H
 
2
 
O
 
2
 
 for 20 min to destroy endogenous peroxidase. Sections
were washed three times in HBS, blocked with 3% BSA/HBS for 30 min,
and then incubated with primary antibodies (1:500 dilution SV2 ascites or
7C8 culture supernatant) at 37
 
8
 
C for 1 h. After washing three times in
HBS, sections were incubated with 1:200 dilution of biotinylated anti–
mouse IgG for 30 min, washed three times in HBS and then further incu-
bated in 1:500 dilution of avidin–biotin complexes for 30 min. Signals were
detected by color reaction (0.05% diaminobenzidine tetrahydrochloride
in 50 mM Tris, pH 7.2, and 0.03% H
 
2
 
O
 
2
 
). The peroxidase reaction was
stopped by transferring to distilled water. Stained specimens were then
mounted for viewing in the light microscope.
 
NE Release from Intact and Semi-intact PC12 Cells
 
To monitor the release of neurotransmitter from semi-intact cells, PC12
cells were labeled with [
 
3
 
H]NE, washed, removed from culture dishes in
cold K glutamate buffer (120 mM K glutamate, 20 mM K acetate, 2 mM
EGTA, 0.1% bovine serum albumin, and 20 mM Hepes, pH 7.2), and per-
meabilized by passage through a narrow clearance ball homogenizer (Hay
and Martin, 1992; Banerjee et al., 1996). These semi-intact cells were
washed extensively and preincubated for 30 min at 30
 
8
 
C in priming incu-
bations that contained K glutamate buffer plus 2 mM MgATP and 1 
 
m
 
g/ml
rat brain cytosol (Hay and Martin, 1992). After this priming step, the semi-
intact cells were washed and incubated with antibodies for 60 min at 0
 
8
 
C.
Ca
 
2
 
1
 
-stimulated release was triggered by the addition of rat brain cytosol
(final concentration 
 
5
 
 0.5 mg/ml) and Ca
 
2
 
1
 
 (final free concentration 
 
5
 
10 mM), and incubating this suspension at 30
 
8
 
C (Hay and Martin, 1992).
After 5 min of incubation, release was terminated by chilling the suspen-
sion to 0
 
8
 
C and centrifuging the samples at 1,000 
 
g
 
, followed by determi-
nation of [
 
3
 
H]NE in the supernatants. Values for Ca
 
2
 
1
 
-dependent release
were obtained by subtracting the amount of [
 
3
 
H]NE released in the ab-
sence of Ca
 
2
 
1
 
 and cytosol; this Ca
 
2
 
1
 
-independent release was a minor
component (
 
,
 
20%) of the total release observed.
 
Results
 
Identification of the 7C8 Antigen as a Vesicle Protein
 
We screened several hundred monoclonal antibodies
raised against purified PC12 cell vesicle membranes by dot
blot immunoassay and immunofluorescence microscopy.
Several antibodies exhibited binding to one or both peaks
of gradient-purified vesicles, and showed a punctate stain-
ing pattern in NGF-differentiated PC12 cells. Antibodies
exhibiting these characteristics were further analyzed by
Western blotting. Some of these antibodies recognized
previously described antigens (e.g., synaptophysin), and
some bound to multiple bands on blots, but several bound
specifically to single bands that did not correspond to
known vesicle proteins. An example of this last category
was the clone designated 7C8.
The initial identification of the 7C8 antigen is shown in
Fig. 1. Fig. 1 
 
A
 
 illustrates the cofractionation of 7C8 bind-
ing with both populations of regulated secretory vesicles in
PC12 cells. The cells were loaded overnight with [
 
3
 
H]NE,
harvested, and homogenized; cellular components were
then fractionated on a sucrose density gradient, and the
fractions analyzed for the presence of various vesicle
markers. As indicated by the circles, 7C8 binding exhib-
ited a bimodal pattern, with peaks in both the lower
(denser) third of the gradient and a second, smaller peak
in the upper third of the gradient. The lower peak corre-
sponds to the location of the NE-containing LDCVs
(Schweitzer and Kelly, 1985), as shown by the single peak
of [
 
3
 
H]NE peak (Fig. 1 
 
A
 
, 
 
diamonds
 
). The upper peak cor-
responds to the location of the cholinergic SSVs (Blum-
berg and Schweitzer, 1992), as shown by the second peak
of SV2 (
 
squares
 
), which is a component of both SSVs and
LDCVs. This distribution was not simply the result of all
cellular or vesicular proteins sedimenting in this fashion; in
contrast to 7C8 and SV2, another of the monoclonal anti-
bodies we isolated, denoted 15C12, showed a single peak
of binding corresponding only to the denser of the two
peaks of 7C8 binding (
 
triangles
 
). In experiments to be de-
scribed elsewhere, we have shown that this antigen is an
integral membrane protein associated exclusively with the
LDCVs (data not shown).
It is clear from this analysis that the 7C8 antigen copuri-
fied with both the catecholamine-containing LDCVs (Fig.
1 
 
A
 
, fractions 
 
6–10
 
) and the lower density SSVs (fractions
 
13–15
 
). As is typical for such density gradients, the vesicles
are spread out over several fractions; this probably reflects
the micro-heterogeneity that is observed even in highly
purified preparations of synaptic vesicles (Carlson et al.,
1978). In addition to this spreading, there is a slight varia-
tion in the precise locations of the peaks for the different
vesicle markers. This difference suggests that the relative
amounts of these markers may vary in vesicles of slightly
differing densities.
Fig. 1 
 
B
 
 shows that this antibody bound exclusively and
specifically to a single protein band with a relative mobility
of 27,000. For comparison, Fig. 1 
 
B also shows two known
vesicle antigens, synaptophysin (P38; Jahn et al., 1985;
Wiedenmann and Franke, 1985) and SV2 (Buckley and
Kelly, 1985), both of which are present in PC12 cell vesi-
cles. The protein identified by the 7C8 antibody some-
times appeared on Western blots as a closely spaced dou-
blet rather than a single band (Fig. 1, C and D).
If the 7C8 antigen were a legitimate component of syn-
aptic vesicles, and not a cell culture artifact, it should be
present in high amounts in brain tissue. This prediction is
confirmed by the Western blots shown in Fig. 1, C and D,
demonstrating the presence of a single immunoreactive
band in rat brain tissue, having a slightly higher mobilityJeng et al. Thy-1 Is a Component of Synaptic Vesicles 689
than seen with PC12 cells. These experiments also indi-
cated that the 7C8 antigen was different from known vesi-
cle proteins of similar molecular weight, including rab-3A
(Fig. 1 C), SNAP-25, (Fig. 1 D), and synaptogyrin (Fig. 1
D). In addition to the differences in mobility, these pro-
teins were distinguished by the differences in distribution:
in contrast to the 7C8 antigen, which behaved as an inte-
gral membrane protein (Fig. 1 C and data not shown) and
consistent with previous reports (Darchen et al., 1990; John-
ston et al., 1991), rab 3A was found in both the soluble and
membrane fractions of a rat brain homogenate (Fig. 1 C).
SNAP-25, although exhibiting similar mobility to the 7C8
antigen, did not show the difference in mobility that the
latter exhibited between PC12 cell and brain tissue (Fig. 1
D). Synaptogyrin was present in detectable (not shown)
but much lower amounts in PC12 cells than rat brain,
again in contrast to 7C8 (Fig. 1 D).
We carried out immunofluorescence microscopy to lo-
calize the 7C8 antigen within PC12 cells. Cells used for
these experiments were differentiated with NGF to facili-
tate the visualization of vesicles within different regions of
the cells. Fig. 2 shows a single confocal optical plane of
three NGF-treated PC12 cells after standard fixation and
permeabilization, illustrating the intracellular punctate ap-
pearance of 7C8 staining. Many brightly stained puncta,
with an apparent diameter of z0.4 mm can be seen scat-
tered throughout the cytoplasm, particularly in the termi-
nal swellings of the neurites. In addition, there are numer-
ous smaller and fainter puncta that are not well resolved,
which probably represent vesicles that are smaller than the
resolution limit of the light microscope. Both these puncta
are absent from the nuclei of the cells. This appearance
suggests that the 7C8 antigen is localized to at least two
populations of vesicles in the cytoplasm of PC12 cells. This
impression was confirmed by morphological analysis of
the overall distribution within cells and neurites.
The confocal image shown in Fig. 2 clearly illustrates the
staining of individual vesicles; conventional immunofluo-
Figure 1. Identification of the 7C8 antigen as
a vesicle protein. (A) Distribution of 7C8,
SV2, and 15C12 immunoreactivities and
[3H]NE in fractionated PC12 cell membranes.
PC12 cells were labeled overnight with
[3H]NE, harvested, and homogenized. The
cell homogenate was then fractionated by
equilibrium density centrifugation on a 0.6–
1.6 M sucrose gradient. Aliquots of each frac-
tion were assayed for 7C8, SV2, and 15C12
immunoreactivities by dot blot immunoassay.
Fractions were numbered starting from the
bottom (most dense portion) of the gradient
to the top (least dense). The top three frac-
tions (18–20) contain soluble components
that did not enter the sucrose gradient. (B)
Immunoblots of synaptophysin, 7C8, and
SV2. PC12 cells homogenates were separated
on SDS-PAGE with a 10% gel and blotted
onto a nitrocellulose filter. Separate filter
strips were incubated with anti-synapto-
physin, 7C8, and anti-SV2 antibodies, and
then with peroxidase-labeled goat anti–
mouse antibodies; bands were detected by
ECL. Molecular weight markers are shown
along the left (in kD); note that both stacking
and running gels are included, with the top of
the running gel indicated by O. (C) Compari-
son of distribution and electrophoretic mobil-
ities of rab3A and 7C8 antigens. Homoge-
nates of rat brain (100 mg total protein per
lane) and PC12 cells (200 mg total protein per
lane) were loaded on the gel, separated by
12% SDS-PAGE, transferred to nitrocellu-
lose membranes, and probed with 7C8 and
anti–rab3A antibodies. Brain homogenates
(Brain, H) were further sonicated and frac-
tionated into soluble (Brain, S) and mem-
brane fractions (Brain, P) by high speed cen-
trifugation (100,000 g for 1 h). Antibody
binding was visualized by film detection of
ECL. The positions of molecular weight standards, in kilodaltons, are indicated to the left of each set of films. (D) Comparison of distri-
bution and electrophoretic mobilities of 7C8 antigen, SNAP-25, and synaptogyrin. Homogenates of PC12 cells and rat brain (100 mg to-
tal protein per lane) were separated by 12% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with anti–SNAP-25,
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rescence microscopy, which is not as capable of resolving
individual vesicles, provides more complete information
about the overall distribution of a protein in various re-
gions of a cell. This distribution is of interest because PC12
cells exhibit a differential localization of LDCVs and SSVs,
with the LDCVs being relatively concentrated in the neu-
rite tips, while the SSVs are most prevalent in the perinu-
clear cell bodies (Schweitzer and Paddock, 1990).
A comparison of the localization of 7C8 staining within
NGF-differentiated PC12 cells with that of other vesicle
markers is shown in Fig. 3. Fig. 3 A shows a phase contrast
image of three PC12 cells and their associated neurites,
whereas Fig. 3 B shows the corresponding immunofluores-
cence image of these cells after staining with the 7C8 anti-
body. In this view, both the perinuclear cell bodies (Fig. 3 B,
arrowheads) and the neurite terminals (arrows) exhibit ap-
proximately equal levels of staining with 7C8; this appear-
ance is consistent with the staining pattern illustrated in
Fig. 2 above, combined with the fact that a considerably
greater volume of cytoplasm is contained in the perinu-
clear cell body than in the neurites.
In contrast with the localization of 7C8 staining, markers
selective for either the SSVs or the LDCVs showed dis-
tinctly different staining patterns. Fig. 3 D illustrates the
staining of cells and processes with an antibody against
secretogranin I, a protein that is contained exclusively
within the LDCVs in PC12 cells (Rosa et al., 1985). Al-
though there was some level of staining throughout the
cell, the tips of the neurites (arrows) stained more in-
tensely with the antibody against secretogranin I than did
the cell body, reflecting the relatively larger numbers of
LDCVs that accumulate in the neurite tips as compared
with the cell body. 
Conversely, synaptophysin is an integral membrane pro-
tein that is present predominantly in the SSVs in PC12
cells (Jahn et al., 1985). The localization of synaptophysin
also differed from that of the 7C8 antigen. The staining
pattern for synaptophysin (Fig. 3 F) appeared as the com-
plement of that seen for secretogranin I; that is, the peri-
nuclear cell bodies (arrowheads) stained more brightly than
the neurite tips, reflecting the relatively greater concentra-
tion of SSVs in the cell bodies than in neurite terminals
(Schweitzer and Paddock, 1990).
Previous morphological and biochemical studies have
shown that the vesicle marker SV2 is present on both SSVs
and LDCVs (Wiedenmann and Franke, 1985; Navone et al.,
1986; Lowe et al., 1988). We therefore expected that SV2
staining would appear similar to that of 7C8. The staining
pattern of SV2 is shown in Fig. 3 H; like 7C8, this was of
approximately equal intensity in the perinuclear cell bod-
ies and neurite tips, reflecting its presence in both popula-
tions of secretory vesicles.
For purposes of illustration, cells with short neurites
were chosen for these figures, because it was not feasible
Figure 2. Confocal microscopic localization of 7C8 in NGF-
treated PC12 cells. NGF-treated PC12 cells were fixed, permeabi-
lized, and processed for single-label fluorescence microscopy, and
imaged with a Zeiss laser scanning confocal microscope. The op-
tical plane shown is close to the bottom (attached) surface of the
three cells, so as to include the neurites attached to the substrate
as well as a thin section of the cell body cytoplasm and a small
portion of the nuclei (which are devoid of staining). The thick-
ness of the optical section was 0.67 mm. Although not apparent in
the optical section shown here, the neurite whose terminal ap-
pears in the lower right hand corner is an extension of the cell
nearest the bottom of the figure. Bar, 10 mm.
Figure 3. Immunofluorescent localization of vesicle markers in
NGF-treated PC12 cells. NGF-treated PC12 cells were fixed, per-
meabilized, and labeled with 7C8 (A and B), antisecretogranin (C
and D), antisynaptophysin (E and F), or anti-SV2 (G and H) an-
tibodies. This was followed by the addition of biotinylated sheep
anti–mouse IgG and then Texas red–streptavidin. The phase con-
trast images (A, C, E, and G) corresponding to the immunofluo-
rescence images are shown to the left of each pair. Arrows in-
dicate staining of neurite tips; arrowheads indicate perinuclear
staining. All images are printed at the same magnification; Bar,
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to combine high magnification images of cells with the large
fields necessary to include the terminals of long neurites.
However, we have observed the same patterns of staining
shown in all the panels in Figs. 2 and 3 in cells with neu-
rites as long as 10 cell body diameters in length.
Identification of the 7C8 Antigen as Thy-1
To determine the identity of this novel component of vesi-
cles, we used the 7C8 antibody to screen a PC12 cell
cDNA library in the plasmid expression vector CDM8
(Seed and Aruffo, 1987), and introduced these sequences
into CHO fibroblasts (Liu et al., 1992); wild-type CHO
cells do not express the 7C8 antigen (data not shown).
When replica colonies from z30,000 independent trans-
formants were immunostained with the 7C8 antibody, we
identified 37 colonies positive for antibody binding. We se-
lected 10 of the more intensely positive colonies for fur-
ther analysis. Of these ten, three clones expressed a pro-
tein of z27 kD that comigrated on Western blot analysis
with the 7C8 antigen seen in PC12 cells (data not shown).
We used plasmid rescue to isolate the sequences encod-
ing the 7C8 antigen from the immunoreactive CHO cell
clone. Genomic DNA was extracted from each clone, and
the integrated plasmids were excised, religated, and intro-
duced into transformation-competent E. coli. Because the
stable CHO transformants contained multiple distinct in-
tegrated plasmids, we used Southern analysis to identify
cDNAs common to the three independently isolated CHO
cell clones. The plasmids rescued from one CHO clone
were radiolabeled by random priming and used as a probe
for Southern blots of the other two clones. Two plasmids
were found to be common to all three clones.
To determine which of these two plasmids encoded the
7C8 antigen, we transfected each plasmid separately into
COS cells, and probed Western blots of the cell homoge-
nates with the 7C8 antibody. Only plasmid 112 showed an
immunoreactive protein of the expected size (Fig. 4 A).
Analysis of the 1.6-kb insert showed sequence identity to
rat Thy-1 (Moriuchi et al., 1983; Seki et al., 1985) begin-
ning 16 nucleotides upstream of the initiation codon and
extending through the entire protein-coding regions as well
as an additional 1,053 base pairs of 39 untranslated DNA.
Thy-1 is a GPI-linked protein known to be on the surface
of T lymphocytes and mature neurons, and has an appar-
ent molecular weight of z27 kD; it has been reported to
run occasionally as a doublet due to heterogeneity in its
N-linked glycosylation (Barboni et al., 1995).
To confirm the specificity of the identification proce-
dure, we further subcloned the 1.6-kb insert into another
plasmid expression vector (pcDNA I-Amp) in both sense
and antisense orientations. After transfection into COS
cells, Western blot analysis with the 7C8 antibody con-
firmed the presence of an immunoreactive protein only
from the construct in the sense orientation (Fig. 4 B).
Biochemical experiments confirmed that the 7C8 anti-
gen is Thy-1. Fig. 5 A shows that the 7C8 antibody binds to
the same protein recognized by a commercially available
monoclonal antibody against Thy-1 (OX7). We immuno-
precipitated Thy-1 from a detergent extract of a PC12 cell
postnuclear supernatant. As shown in the first panel, illus-
trating an immunoblot probed with the same OX7 anti–
Thy-1 antibody used for the immunoprecipitation, all of
the Thy-1 in the homogenate was pelleted in the immuno-
precipitation; in contrast, normal mouse serum leaves all
the Thy-1 in the supernatant. The second panel in Fig. 5 A
illustrates that probing these samples with the 7C8 anti-
body gives exactly the same pattern as for OX7; i.e., the
7C8 antigen is precipitated by the OX7 antibody, but not
by control serum. A comparison of the two panels in Fig. 5 A
also illustrates the identical mobility of the proteins recog-
nized by these two antibodies.
To demonstrate even more conclusively that 7C8 recog-
nizes Thy-1, we made use of the fact that mice express two
different allotypes of Thy-1, known as Thy-1.1 and Thy-
1.2. Thy-1.1, which is expressed by the AKR strain of
mouse, is nearly identical to rat Thy-1; BALB/c mice, on
the other hand, express Thy-1.2, which is different enough
that it does not cross-react with anti–Thy-1 antibodies
(Marshak-Rothstein et al., 1979). Fig. 5 B shows a panel of
homogenates from PC12 cells, rat brain, BALB-C mouse
brain, and AKR mouse brain probed with the OX7 or 7C8
antibodies. As was shown in Fig. 1, Fig. 5 B shows that the
7C8 antigen was present in both PC12 cells and rat brain;
the same was true of Thy-1 visualized by the OX7 anti-
body. Most strikingly, there was no immunoreactivity in
BALB/c mouse brain with either OX7 or 7C8 antibodies,
although in brain tissue from AKR mice, immunoreactiv-
ity was present that comigrated with rat Thy-1. These ex-
periments demonstrate unequivocally that the 7C8 anti-
body recognizes a protein that is identical to Thy-1.
Cell Surface Versus Internal Thy-1
Because Thy-1 has previously been considered to be only
a marker for the plasma membrane, it was important to
ask why we did not observe 7C8 binding to the cell surface
as well as to vesicles. It was also essential to determine un-
ambiguously that the Thy-1 we observed as a component
of vesicles was not contamination from the plasma mem-
brane. To address the former question, we carried out im-
munofluorescent staining of nonfixed, nonpermeabilized
PC12 cells to determine whether we could observe surface
staining. As shown in Fig. 6, binding of the antibody to the
cells before fixation and detergent treatment resulted in
intense staining around the periphery of the cell, consis-
tent with staining of the plasma membrane. Our standard
procedure for immunofluorescence involved fixing cells
and then permeabilizing with 0.1% Triton X-100 for 2 min.
Figure 4. Expression of the
7C8 antigen in COS cells. (A)
Homogenates of COS cells
transfected with two of the
pcDM8 expression plasmids
isolated from immunoreac-
tive CHO cell clones were
stained on a Western blot with the 7C8 antibody. Clone 112 ex-
pressed a protein that comigrated with the 7C8 antigen expressed
by PC12 cells, but untransfected COS cells (2) and cells trans-
fected with plasmid 11 did not. (B) The cDNA insert from plas-
mid 112 was subcloned into the expression vector pcDNA I-Amp.
Homogenates from COS cells transfected with the cDNA insert
in the sense (S) but not the antisense (A) of the Thy-1 cDNA re-
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Although we occasionally observed such surface staining
with conventionally fixed and permeabilized cells (data
not shown), we routinely observed only the vesicular stain-
ing illustrated in Figs. 2 and 3. Why the plasma membrane
Thy-1 is preferentially lost during standard fixation and
permeabilization, even as the intracellular staining is re-
tained, is not completely clear at this point. However, per-
haps because of its GPI anchor, Thy-1 is known to present
unusual difficulties for morphological localization (Morris
and Grosveld, 1989).
To demonstrate unequivocally that there is intracellular
Thy-1 associated with secretory vesicles, and to quantitate
the distribution of Thy-1 between intracellular and surface
membranes, we used a procedure for immunopurifying
secretory vesicles from PC12 cells with a monoclonal anti-
body that is directed against a cytoplasmic epitope of the
SV2 protein (Schweitzer and Kelly, 1985). Figs. 7 and 8
show experiments using such an immunopurification pro-
cedure to demonstrate that Thy-1 is specifically and pre-
dominantly associated with vesicles.
For Fig. 7 A, a postnuclear supernatant from a PC12 cell
homogenate was immunoprecipitated (in the absence of
any detergent) with antibody against SV2, which should
precipitate both the LDCVs and the SSVs, leaving nonve-
sicular membranes, including plasma membrane, in the su-
pernatant. About half of the immunoreactive Thy-1 was
recovered in the supernatant, and half in the immunopre-
cipitated pellet (Fig. 7 A, lanes 2 and 3). Quantitative anal-
ysis of these bands from three experiments gave a figure of
56 6 9% vs. 44 6 9% for the actual distribution of vesicu-
lar Thy-1 versus plasma membrane Thy-1. No Thy-1 was
precipitated by normal mouse serum (lanes 4 and 5). To
demonstrate that all the vesicles are precipitated by this
procedure, the same samples were probed with an anti-
body against synaptophysin; essentially all of this vesicle
marker precipitated with the SV2 antibody (lanes 7 and 8).
To show that this procedure did not simply cause all the
cellular proteins to precipitate nonspecifically, we also vi-
sualized the total protein in each of these samples by sil-
ver-staining a parallel gel (Fig. 7 B). It is clear that the vast
majority of the protein remained in the supernatant after
immunoprecipitation with SV2 antibody (lanes 2 and 3); in
terms of total protein, the SV2-immunoprecipitated lane
was barely distinguishable from the normal mouse serum
control, except for the presence of the immunoglobulin
bands (compare lanes 3 and 5). We therefore conclude
that this immunoprecipitation procedure is a highly selec-
Figure 5. Identification of 7C8 antigen as Thy-1. (A) OX7 immu-
noprecipitation. Postnuclear supernatant of PC12 cells (PC12 S1)
was solubilized with Det-HBS, and immunoprecipitated with OX7
coated-SAC (OX7) or with normal mouse serum coated-SAC
(NMS). Supernatant (S) and pellet (P) fractions after low speed
centrifugation were subjected to a nonreducing SDS-PAGE and
immunoblotting with OX7 (lanes 1–5) or 7C8 (lanes 6–10) anti-
bodies. (B) Immunoblots of OX7 and 7C8. Homogenates (100 mg
total protein per lane) of PC12 cells, rat brain, BALB/c mouse
brain, and AKR mouse brain were loaded on a nonreducing gel,
transferred to nitrocellulose membranes, and probed with OX7
(lanes 1–4) or 7C8 (lanes 5–8) antibodies.
Figure 6. Immunofluorescent staining of non-
permeabilized PC12 cells with 7C8. NGF-
treated PC12 cells were incubated with 7C8
antibodies at 08C for 1 h before fixation. Af-
ter fixation, cells were incubated with biotiny-
lated sheep anti–mouse antibodies, followed
by Texas red-streptavidin. Bar, 10 mm. A and
B represent the phase contrast and fluores-
cence images of the same cells; C represents a
single confocal optical section through a dif-
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tive and effective method to separate secretory vesicles
from other cellular components.
A similar experiment was carried out to demonstrate that
the presence of Thy-1 in vesicles was not typical of plasma
membrane proteins. In Fig. 7 C, SV2-immunopurified mem-
branes were run on parallel gels, transferred to nitrocellu-
lose, and probed with antibodies against the plasma mem-
brane Na pump, synaptophysin, or Thy-1. Because of the
lability of the Na pump immunoreactivity, these immuno-
precipitations were carried out using incubations of only
15 min, but a comparison of Fig. 7 C, lanes 2 and 3, demon-
strates that nearly all of the synaptic vesicle marker synap-
tophysin appeared in the immunoprecipitation pellet (lane
3). In contrast, all of the plasma membrane marker re-
mained in the immunoprecipitation supernatant (lane 2),
just as in the case of the control precipitation with normal
mouse serum (lane 4). As in the experiment shown in Fig.
7 A, approximately half of the Thy-1 immunoprecipitated
along with the vesicles (lane 3). The association of Thy-1
with vesicles is, therefore, distinct from the behavior of
other plasma membrane proteins such as the Na pump.
To be additionally certain that the Thy-1 that appeared
in the SV2 pellet did not represent contamination from
plasma membrane, we biotinylated the surface proteins of
intact cells to extend this analysis even further. In this
case, after immunopurifying vesicles using anti-SV2, we
solubilized the membranes and quantitatively immunopre-
cipitated Thy-1 protein using the OX7 antibody. The re-
sulting samples were used for Western blot analysis using
the 7C8 monoclonal antibody to visualize total Thy-1 pro-
tein (Fig. 8 A), and streptavidin to visualize the biotiny-
lated proteins derived from the plasma membrane (Fig. 8 B).
Fig. 8 A, lanes 7 and 8, show the same result as show in Fig.
7 A; immunoprecipitation with anti-SV2 coimmunoprecip-
itated approximately half of the total Thy-1. After the sec-
ond immunoprecipitation, carried out with anti–Thy-1 in
the presence of detergent, all the Thy-1 was recovered in
the pellet (Fig. 8 A, lanes 3 and 5). When the SV2-immu-
noprecipitated pellets were probed with streptavidin (Fig.
8 B), essentially all (93 6 10%, n53) of the biotinylated
Thy-1 was present in the SV2 supernatant (Fig. 8 B, lane
3); only trace amounts (7 6 10%) appeared in the SV2 pel-
let (Fig. 8 B, lane 5). This amount is clearly insufficient to
account for the z60% of the total Thy-1 that is immuno-
precipitated along with the vesicles (Fig. 8 A, lanes 3 and
5). This result demonstrates unequivocally that a major
fraction of the Thy-1 protein is a component of the SV2-
containing regulated secretory vesicles in PC12 cells.
Thy-1 Is a Component of Synaptic Vesicles in Rat Brain
To demonstrate that the vesicular localization of Thy-1 is
not unique to the PC12 cell line, we analyzed rat brain tis-
sue for the presence and localization of Thy-1. Western
blot analysis of various brain regions and other tissues
demonstrated that 7C8 bound to virtually all synapse-con-
taining regions of the central nervous system, but was un-
detectable in peripheral tissues, including liver, kidney,
pancreas, and muscle (data not shown). Extensive immu-
nohistochemical mapping of the distribution of 7C8 bind-
ing throughout the nervous system showed that 7C8 bind-
ing was prominent in the gray matter in synapse-rich areas,
and that this staining paralleled that seen with other vesi-
cle markers. One example of this general colocalization is
shown in Fig. 9 A, in which the synaptic layers of the hip-
pocampus stain prominently with 7C8 (A), SV2 (B), and
synaptophysin (C). Although we can identify subtle differ-
ences in the relative staining of vesicles markers in some
regions (for example, in the dentate gyrus of the hippo-
campus, there is relatively less SV2 staining in the vicinity
of the granule cell layer as compared with 7C8 or synapto-
physin); most areas show similar staining of all these vesi-
cle markers. This result suggests that Thy-1 is somehow as-
sociated with synapses.
Figure 7. Presence of Thy-1 in immunopurified vesicles and non-
vesicular membranes. SV2-containing vesicles were precipitated
from postnuclear supernatant of PC12 cells (PC12 S1) by incu-
bating with anti–SV2-coated SAC (SV2) or with normal mouse
serum coated-SAC (NMS), and then separating the membranes
bound to the immuno-SAC (P) from the unbound cellular com-
ponents (S) by low speed centrifugation. Samples were subjected
to a nonreducing gel for blotting with 7C8 (A, lanes 1–5) or a re-
ducing gel for blotting with antisynaptophysin antibodies (A, lanes
6–10). B shows a silver-stained gel of equal amounts of the same
samples used for the immunoblots in A. C shows samples from
similar immunoprecipitation experiment probed for the a subunit
of the Na pump (8% acrylamide-nonreducing gel), synaptophysin
(10% acrylamide-reducing gel), or Thy-1 (10% acrylamide-non-
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Despite being consistent with a synaptic localization of
Thy-1 in the central nervous system, immunohistochemi-
cal staining at the light microscopic level is inadequate to
determine the subcellular localization of the Thy-1 visual-
ized by the 7C8 antibody. To determine whether Thy-1 is
an intrinsic component of synaptic vesicles, we analyzed
purified synaptic vesicles prepared by a series of differen-
tial centrifugation, Nycodenz density gradient, and sizing
column procedures (Floor et al., 1995). Fig. 7, D–F, shows
the final step in this purification, consisting of a Sephacryl
S-1000 sizing column. This separation not only produces
highly purified synaptic vesicles, but can resolve the small
synaptic vesicles from the larger, peptide-containing vesi-
cles (Floor et al., 1988). The extent of plasma membrane
contamination of these vesicles is very low; Na/K ATPase
(ouabain-sensitive) activity accounts for ,5% of the total
ATPase activity found in the SSV fractions (Floor et al.,
1990). When Nycodenz-enriched membranes were loaded
onto the Sephacryl S-1000 column, very large membranes
and membrane fragments passed through the column in
the void volume (fractions 24–30); large, peptide-contain-
ing vesicles were included and eluted in fractions 33–37;
and highly purified small synaptic vesicles eluted in frac-
tions 41–47. As seen in Fig. 9 D, 7C8 immunoreactivity co-
purified with both the large and small vesicle peaks, con-
sistent with its localization in PC12 cells. In contrast, the
synaptic vesicle markers synaptophysin (Fig. 9 E) and SV2
(Fig. 9 F) were predominantly associated with the small
synaptic vesicles in brain. Similar results were obtained with
SSVs purified on controlled pore glass columns (data not
shown). The observation that Thy-1 copurifies with highly
enriched preparations of synaptic vesicles argues strongly
that the vesicular localization observed in PC12 cells is also
present in vivo in brain synapses.
We observed one notable exception to the colocaliza-
tion of Thy-1 with other vesicle markers. In the retina, the
difference between the staining patterns for Thy-1 and
other synaptic vesicle markers was striking. As shown in
Fig. 9 G, Thy-1 staining was intense in the retinal ganglion
cells, but was completely absent from the outer plexiform
layer, and very faint in the inner plexiform layer. The pres-
ence of other synaptic vesicle markers in these layers is il-
lustrated by Fig. 7, H and I, in which SV2 and synapto-
physin were visualized; both these vesicle proteins stained
prominently in both the inner and outer plexiform layers.
The absence of Thy-1 staining in the plexiform layers of
the retina correlates with the presence in these locations of
structurally unique and physiologically distinct synapses
(ribbon synapses, see Discussion).
Functional Involvement of Thy-1 in the Release
of Neurotransmitter
Because of its presence in synaptic vesicles and its localiza-
tion in areas of synaptic contact, it was of interest to deter-
mine whether Thy-1 plays some demonstrable role in the
release of neurotransmitter. Because Thy-1 on the inside
of the vesicles is highly inaccessible, we chose to examine
whether surface Thy-1 might contribute in some functional
way to the regulated release of neurotransmitter. Using a
semi-intact PC12 cell preparation (Walent et al., 1992), we
examined the effect of anti–Thy-1 antibodies on Ca21-reg-
ulated neurotransmitter release. In this preparation, the
plasma membranes of PC12 cells have been sheared to make
them permeable to large molecules, as the organization of
the synaptic vesicles and release sites remains sufficiently
intact to observe regulated NE release that is dependent
on Ca21 and cytosolic components (Hay and Martin, 1992;
Walent et al., 1992; Hay et al., 1995). This preparation has
been useful for identifying other molecular components of
the regulated secretory apparatus (Banerjee et al., 1996).
As illustrated in Fig. 10, preincubation of the semi-intact
PC12 cells with purified 7C8 antibody reproducibly pro-
duced a partial inhibition of the Ca21-dependent portion
of NE release. Fig. 10 shows that this inhibition (35% in
this case) did not increase further with increased amounts
of antibody. In contrast, the addition of similar concentra-
tions of a different monoclonal antibody, directed against
the cytoplasmic portion of the synaptic vesicle component
SV2, had no effect on the stimulated release of NE. Be-
cause SV2 is present on the NE-containing vesicles (Schweit-
zer and Kelly, 1985; Blumberg and Schweitzer, 1992; also
see above), this result argues that this assay is relatively in-
sensitive to nonspecific steric hindrance effects. In addi-
tion, it seems unlikely that a nonspecific effect could re-
producibly inhibit a constant fraction of the Ca21-stimulated
release. Although the concentration of antibody required
to produce this inhibition is quite high, we have observed
similarly high requirements for other antibodies that exert
an inhibitory effect in this semi-intact cell system (unpub-
lished data). Because this system does not depend on Ca21
Figure 8. Biotinylation of surface but not vesicular Thy-1. Living
PC12 cells were surface biotinylated by incubation with sulfo-
NHS-LC-biotin for 30 min at 08C. The cells were then harvested,
rinsed, and homogenized. Supernatant and pellet fractions from
SV2-immunoisolation procedures, performed exactly as described
in Fig. 7, were solubilized with detergent and further immunopre-
cipitated with OX7-coated SAC. Samples were subjected to a non-
reducing gel for probing with 7C8 antibodies (A) or HRP-labeled
streptavidin (B) to visualize total Thy-1 and biotinylated cell sur-
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channels to control the [Ca21] in the vicinity of the release
apparatus, the inhibition observed here is not mediated by
an effect on the presynaptic Ca21 channel.
The inhibitory effect of anti–Thy-1, taken together with
the widespread distribution of Thy-1 and its presence in
multiple populations of synaptic vesicles, strongly suggests
a fundamental role for Thy-1 in the events that mediate
regulated synaptic vesicle fusion in phasic synapses in the
central nervous system.
Discussion
We were surprised to learn that Thy-1 is a component of
synaptic vesicles, and even more so to find it a component
of each of the regulated secretory vesicles that we have ex-
amined, suggesting that it plays some fundamental role in
the structure and/or function common to various types of
secretory vesicles. The existence of Thy-1 has been recog-
nized for over 30 years; how can we explain the fact that its
presence in secretory vesicles was not previously appreci-
ated?
Thy-1 is an unusual membrane protein belonging to the
class of GPI-linked integral membrane proteins whose
transmembrane domain is cleaved during biogenesis. It ex-
hibits somewhat unexpected biochemical and histological
properties, as shown by its heterogeneous sensitivity to
phospholipase C (Low et al., 1988; Wilkerson and Touster,
1993), and its unusual behavior after reduction, removal of
its lipid tail (Barboni et al., 1995), or fixation (Morris and
Grosveld, 1989). Despite these anomalies, its presence in
the plasma membrane of neurons was well recognized, but
was viewed mainly as simply a cell surface marker. It has,
however, been reported to accumulate proximal to a nerve
Figure 9. Localization of Thy-1 immunoreac-
tivity in rat brain. (A–C) Localization of 7C8
immunoreactivity in the hippocampus. Sec-
tions of rat hippocampus were stained for
Thy-1 (A), SV2 (B), or synaptophysin (brown
HRP reaction product), and counterstained
with methylene green. In coronal sections of
the hippocampus, 7C8 immunoreactivity was
found throughout the synaptic fields, includ-
ing the stratum oriens, stratum radiatum, and
the molecular layer of the dentate gyrus. In
contrast, there was nothing labeled with the
antibody in the pyramidal cell layer, stratum
lacunosum moleculare and granular layer of
the dentate gyrus. Both SV2 and synapto-
physin immunoreactivities were similar to
that of Thy-1, and were distributed through-
out the synaptic fields, but not in the cell
body layers. (D–F) Thy-1 copurifies with
large and small synaptic vesicles. The distri-
bution of Thy-1 (D), SV2 (E), and synapto-
physin (F) immunoreactivities were assayed
by dot blot after fractionation of membranes
by Sephacryl S-1000 column chromatography.
The three arrows indicate the positions of the
void volume of the column (V0), the elution
position of large, dense-core vesicles (LDV),
and the elution position of the small synaptic
vesicles (SSV). Data shown are the mean 6
range of duplicated determinations. (G–I)
Localization of 7C8 immunoreactivity in the
retina. Sections of rat retina were stained for
immunoreactivity to 7C8 and then counter-
stained with methylene green. The sections
are oriented with the photoreceptor layer at
the bottom. 7C8 immunoreactivity was prom-
inently in the ganglion cell layer (gc) and
faintly in the inner plexiform layer (ip). In
contrast to SV2 (H), and synaptophysin (I),
7C8 immunoreactivity was largely absent
from the inner nuclear layer (in), outer plexi-
form layer (op), and outer nuclear layer (on).
Bars: (A–C) 500 mm; (G–I) 100 mm.The Journal of Cell Biology, Volume 140, 1998 696
constriction (Morris et al., 1983), which is consistent with
its presence in some sort of intracellular vesicle.
We report here that Thy-1 is not only a component of
regulated secretory vesicles, but that a major portion
(.50% in PC12 cells) of Thy-1 is found in the vesicles, as
compared with the cell surface. We have confirmed the
presence of Thy-1 in distinct populations of synaptic vesi-
cles purified from brain, and observed that Thy-1 is dis-
tributed in virtually all regions of the central nervous sys-
tem with a distribution that generally parallels that of
other synaptic vesicle proteins. We do not yet know the
detailed relationship between vesicular Thy-1 and cell sur-
face Thy-1. Whether one serves as a precursor to the
other, and whether the relative distribution between these
two sites can be altered by nerve activity or other condi-
tions will require detailed cell biological analysis to deter-
mine. It is clear, however, that a major portion of the Thy-1
in cells is associated with the secretory vesicles, where it is
presumably attached to the lumenal leaflet of the bilayer.
In this orientation, Thy-1 would be able to interact with
neurotransmitters, peptides, or other soluble components
of the secretory vesicles. In addition, although we do not
provide evidence for this here, we presume that this inter-
nal Thy-1 becomes exposed on the surface of the cell spe-
cifically at the synapse when these vesicles fuse with the
presynaptic plasma membrane, i.e., in an activity-depen-
dent manner. Although most synaptic vesicle proteins be-
come externalized only transiently as a result of fusion of
synaptic vesicles with the plasma membrane, it seems that
a significant fraction of Thy-1 is retained on the cell sur-
face, where it has the potential to interact with extracellu-
lar molecules in the synaptic cleft.
The specific targeting of Thy-1 to the presynaptic termi-
nal fits well with our understanding of sorting and target-
ing in polarized epithelial cells, where GPI-linked proteins
are selectively targeted to the apical membrane (Lisanti
et al., 1989). There is considerable evidence that the axon
versus dendrite polarity of neurons is analogous to the api-
cal versus basolateral membrane polarity in epithelial cells
(Cameron et al., 1993). In fact, there are subtle differences
between the localization of GPI-linked Thy-1 and a modi-
fied version containing a transmembrane tail (Tiveron et al.,
1994). Whether packaging of Thy-1 into vesicles is merely
a means of directing its insertion selectively into the pre-
synaptic plasma membrane, or whether Thy-1 plays some
additional role in vesicle dynamics, is not completely clear.
However, its presence in multiple populations of vesicles,
including the small synaptic vesicles that have undergone
multiple rounds of fusion and recycling from the plasma
membrane, suggests the likelihood that its continued pres-
ence in vesicles is significant.
With respect to the functional role that Thy-1 may play
in synaptic vesicle dynamics, we find it intriguing that the
one synapse-rich location in the central nervous system
where we observe a striking lack of Thy-1 is the inner and
outer plexiform layers of the retina, correlating with the
presence of unusual ribbon synapses (Dowling et al., 1966).
In the outer plexiform layer that contains exclusively rib-
bon synapses formed by the photoreceptor cells, Thy-1 is
virtually absent; in the inner plexiform layer, where there
is a mix of ribbon synapses formed by bipolar cells and of
conventional synapses formed by amacrine cells, Thy-1 is
low but detectable; this Thy-1 is not contributed by the
ganglion cells (Perry et al., 1984). In contrast to conven-
tional phasic synapses, ribbon synapses are tonically ac-
tive, and are down modulated by visual stimulation of the
photoreceptors; they also have a unique set of proteins that
differs from conventional synapses (Schmitz et al., 1996).
Although the reason for this correlation between function
and Thy-1 is not clear at present, it would be interesting to
determine whether Thy-1 is absent from ribbon synapses
in the vestibular apparatus (Ross, 1993).
Although Thy-1 does not itself span the lipid bilayer, it
has been observed to modulate some intracellular functions,
most notably intracellular Ca21 and kinase activity (Kroc-
zek et al., 1986; Hsi et al., 1989; Barboni et al., 1991; Gar-
nett et al., 1993). Most recently, knockout mice lacking
Thy-1 have been observed to exhibit a deficit in LTP in the
dentate gyrus of the hippocampus (Nosten-Bertrand et al.,
1996). We report here that adding antibody against Thy-1
decreases the amount of neurotransmitter release in two
preparations that consist exclusively of presynaptic ele-
ments, that is, in the absence of postsynaptic cells. We,
therefore, suggest that the effects on LTP seen in knock-
out mice are a result of presynaptic alterations in the
amount of neurotransmitter released at the hippocampal
synapses lacking Thy-1. The intermediate steps in this in-
hibition of transmitter release are unknown, but are cur-
rently under investigation. The large amounts of antibody
needed to produce this inhibition may well be related to
the fact that most current models of Thy-1 acting as a sig-
nal transduction element invoke cross-linking and aggre-
gation of this protein (Mahanthappa and Patterson, 1992).
Because knockout mice lack Thy-1 during development
as well as in the adult, Thy-1 may also play a long-term
role in synapse formation and maintenance that would not
Figure 10. Effect of antibodies on NE release from semi-intact
PC12 cells. ATP-primed, semi-intact PC12 cells were incubated
with the indicated amount of purified antibody (m, 7C8; or d,
anti-SV2) for 60 min at 08C before conducting 5 min Ca21-trig-
gering incubations as described in Materials and Methods. Incu-
bations were conducted in duplicate with ranges indicated by er-
ror bars. All values were adjusted by subtracting the amount of
background release in the absence of Ca21 and cytosol.Jeng et al. Thy-1 Is a Component of Synaptic Vesicles 697
be observed in our cell culture systems. However, as we do
observe an inhibition of neurotransmitter release after an
acute application of antibody, it is clear that Thy-1 is in-
volved in some short-term aspect of the process of synap-
tic activity. Because we observe such an inhibition both in
intact cells and in cells whose plasma membranes have
been disrupted, it is clear that this effect must be on the se-
quence of events between the increase in intracellular Ca21
and the fusion of the neurotransmitter-containing vesicles.
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